# Theravance Z Score

THRX -- USA Stock

## null 9.819.819,223,372,036,855%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Also please take a look at World Market Map.
 Symbol

## Z Score Analysis

Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in late 1960s at New York University..
Theravance
 Z Score = Sum Of 5 Factors
=
-4.2
 First Factor = 1.2 * ( Working Capital / Total Assets )
 Second Factor = 1.4 * ( Retained Earnings / Total Assets )
 Thrid Factor = 3.3 * ( EBITAD / Total Assets )
 Fouth Factor = 0.6 * ( Market Value of Equity / Total Liabilities )
 Fifth Factor = 0.99 * ( Revenue / Total Assets )

To calculate Z-Score one would need to know current working capital of the company, its total assets and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1 indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.Compare to competition
Theravance has Z Score of -4.2. This is much lower than that of the sector, and significantly lower than that of Z Score industry, The Z Score for all stocks is over 1000% higher than the company.

## Peer Comparison

Theravance Z Score Comparison
 Z Score
 Theravance Comparables
Theravance is currently under evaluation in z score category among related companies.

## Did you try this?

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity

## Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
 Explore Investing Ideas

## Fundamental Indicators

Current Theravance financial ratios
 Return On Asset 1.82 % Profit Margin (101.55) % Operating Margin 37.55 % Current Valuation 1.78 B Shares Outstanding 117.44 M Shares Owned by Insiders 30.95 % Shares Owned by Institutions 86.00 % Number of Shares Shorted 24.88 M Price to Earning 737.67 times Price to Book 9.27 times Price to Sales 32.45 times Revenue 38.39 M Gross Profit 8.43 M Net Income (38.99 M) Cash and Equivalents 206.19 M Cash per Share 1.76 times Total Debt 744.09 M Debt to Equity 1.09 % Current Ratio 19.84 times Cash Flow from Operations (1.4 M) Earnings Per Share 0.34 times Number of Employees 13 Beta 3.14 Total Asset 437.63 M Retained Earnings (1.7 B) Working Capital 212.48 M Current Asset 223.75 M Current Liabilities 11.28 M Z Score -4.2